rs34365369

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001927.4(DES):​c.372G>A​(p.Glu124Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00357 in 1,583,166 control chromosomes in the GnomAD database, including 169 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 76 hom., cov: 33)
Exomes 𝑓: 0.0020 ( 93 hom. )

Consequence

DES
NM_001927.4 synonymous

Scores

1
1

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:19

Conservation

PhyloP100: 2.82

Publications

3 publications found
Variant links:
Genes affected
DES (HGNC:2770): (desmin) This gene encodes a muscle-specific class III intermediate filament. Homopolymers of this protein form a stable intracytoplasmic filamentous network connecting myofibrils to each other and to the plasma membrane. Mutations in this gene are associated with desmin-related myopathy, a familial cardiac and skeletal myopathy (CSM), and with distal myopathies. [provided by RefSeq, Jul 2008]
DES Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 1I
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • myofibrillar myopathy 1
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • atrioventricular block
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neurogenic scapuloperoneal syndrome, Kaeser type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 2-219418834-G-A is Benign according to our data. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-219418834-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 44258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.82 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0601 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DESNM_001927.4 linkc.372G>A p.Glu124Glu synonymous_variant Exon 1 of 9 ENST00000373960.4 NP_001918.3 P17661Q53SB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DESENST00000373960.4 linkc.372G>A p.Glu124Glu synonymous_variant Exon 1 of 9 1 NM_001927.4 ENSP00000363071.3 P17661

Frequencies

GnomAD3 genomes
AF:
0.0179
AC:
2730
AN:
152214
Hom.:
74
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0618
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00687
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.00430
AC:
860
AN:
200182
AF XY:
0.00307
show subpopulations
Gnomad AFR exome
AF:
0.0564
Gnomad AMR exome
AF:
0.00343
Gnomad ASJ exome
AF:
0.00142
Gnomad EAS exome
AF:
0.000132
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000590
Gnomad OTH exome
AF:
0.00366
GnomAD4 exome
AF:
0.00203
AC:
2899
AN:
1430836
Hom.:
93
Cov.:
92
AF XY:
0.00184
AC XY:
1307
AN XY:
708732
show subpopulations
African (AFR)
AF:
0.0667
AC:
2200
AN:
32972
American (AMR)
AF:
0.00366
AC:
145
AN:
39664
Ashkenazi Jewish (ASJ)
AF:
0.00110
AC:
28
AN:
25542
East Asian (EAS)
AF:
0.0000260
AC:
1
AN:
38440
South Asian (SAS)
AF:
0.000122
AC:
10
AN:
82024
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50786
Middle Eastern (MID)
AF:
0.00995
AC:
57
AN:
5726
European-Non Finnish (NFE)
AF:
0.000154
AC:
169
AN:
1096392
Other (OTH)
AF:
0.00487
AC:
289
AN:
59290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
184
368
553
737
921
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0180
AC:
2747
AN:
152330
Hom.:
76
Cov.:
33
AF XY:
0.0177
AC XY:
1315
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0621
AC:
2581
AN:
41582
American (AMR)
AF:
0.00686
AC:
105
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.000367
AC:
25
AN:
68028
Other (OTH)
AF:
0.0147
AC:
31
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
137
274
412
549
686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00940
Hom.:
15
Bravo
AF:
0.0204
Asia WGS
AF:
0.00607
AC:
22
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:19
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 17, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 26, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:6
Jun 22, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This silent variant is not expected to have clinical significance because it doe s not alter an amino acid residue and is not located near a splice junction. Fur thermore, it is present in 7% of the African American population (dbSNP;rs343653 69). -

Feb 10, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 17, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Desmin-related myofibrillar myopathy Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Myofibrillar Myopathy, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dilated cardiomyopathy 1I Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Neurogenic scapuloperoneal syndrome, Kaeser type Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Cardiovascular phenotype Benign:1
Oct 28, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
15
DANN
Uncertain
0.98
PhyloP100
2.8
PromoterAI
-0.10
Neutral
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34365369; hg19: chr2-220283556; COSMIC: COSV104688328; COSMIC: COSV104688328; API